Stay updated on Venetoclax/Azacitidine Maintenance in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page.

Latest updates to the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference8%
- Check21 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.2%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page has been updated to v3.0.2 from v3.0.1. No substantive core content changes are detected, and the 'Back to Top' link was removed.SummaryDifference0.5%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.5%
- Check49 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference79%
- Check57 days agoChange DetectedThe date for results has been updated from June 25, 2025, to August 20, 2025, indicating a delay in the results posting. Additionally, the terminology has changed from 'Results Submitted' to 'Results Posted'.SummaryDifference1.0%
Stay in the know with updates to Venetoclax/Azacitidine Maintenance in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax/Azacitidine Maintenance in AML Clinical Trial page.